Le Lézard
Classified in: Health, Business
Subjects: NPT, LEG, AVO

PAN Foundation celebrates Medicare reforms, new health protections for millions


WASHINGTON, Aug. 16, 2022 /PRNewswire/ -- The PAN Foundation is celebrating after the president signed four key Medicare reforms into law today through the Inflation Reduction Act, legislation that will make prescriptions and vaccines more affordable for 49 million people with Part D coverage.

"PAN has advocated for these Medicare improvements for years, and we are thrilled to see them enacted into law."

The legislation includes, for the first time, an annual limit on what Medicare beneficiaries pay out of pocket for their prescription medications. Beginning in 2025, people on Medicare will spend no more than $2,000 per year out of pocket for their prescription medications and they will have the option to pay monthly, tandem provisions commonly referred to as "cap and smoothing."

For years, PAN has advocated for these commonsense reforms to make prescriptions and vaccines more affordable for people with Medicare Part D insurance. Though Medicare helps adults afford their healthcare, for many?especially those with a serious illness?the out-of-pocket costs are often prohibitive, totaling in the thousands or even tens of thousands. Half of all people with Medicare have incomes below $30,000, and till now, Medicare beneficiaries have been the only insured group in the U.S. who were not protected by an annual limit on their out-of-pocket responsibilities.

Today's bill signing ceremony was the final step to enact these health provisions after the Senate and House voted to pass the Inflation Reduction Act last week. With Congressional approval and President Joe Biden's signature, greater access to care and financial relief is possible for the 49 million older adults and people with disabilities who rely on Medicare Part D for their prescriptions.

The law signed today includes:

"Today marks a huge step toward expanded healthcare access. These four Medicare reforms will mean grandparents don't have to choose between groceries and prescriptions. They will mean that the price of a vaccine won't stop someone with a chronic condition from getting immunized," said PAN President and CEO Kevin L. Hagan. "Ultimately, they mean improved health outcomes for 49 million people. This legislation will change lives."

PAN's Executive Vice President Amy Niles, who leads public policy and advocacy initiatives, echoed his enthusiasm for these reforms. 

"PAN has advocated for these Medicare improvements for years, and we are thrilled to see them enacted into law, particularly the annual cap," she said. "I'd also like to thank the PAN advocates who sent tens of thousands of emails to their elected officials over the last few years sharing the impact these reforms would have on their health and lives. Today, their voices have been heard."

The PAN Foundation has long advocated for cap and smoothing for Medicare Part D and other patient-first measures. Read about our advocacy work.   

About the PAN Foundation

The PAN Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic, and rare diseases with the out-of-pocket costs for their prescribed medications.

Since 2004, we have provided more than 1 million underinsured patients with $4 billion in financial assistance. Partnering with generous donors, healthcare providers and pharmacies, we provide the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. Learn more at panfoundation.org.

Contact: Liz Eckert, [email protected]

SOURCE PAN Foundation


These press releases may also interest you

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...



News published on and distributed by: